Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00285_DB00701> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00285_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00285_DB00701 label "DDI between Venlafaxine and Amprenavir - Amprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Amprenavir is initiated, discontinued, or dose changed. [drugbank_resource:DB00285_DB00701]" assertion.
- drugbank_resource:DB00285_DB00701 identifier "drugbank_resource:DB00285_DB00701" assertion.
- drugbank_resource:DB00285_DB00701 title "DDI between Venlafaxine and Amprenavir - Amprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Amprenavir is initiated, discontinued, or dose changed." assertion.